Scarica l'app Stockscreener
13.77
4.48%
0.59
Dopo l'orario di chiusura:
13.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Precedente Chiudi:
$13.18
Aprire:
$13.33
Volume 24 ore:
538.28K
Relative Volume:
1.01
Capitalizzazione di mercato:
$740.44M
Reddito:
$217.25M
Utile/perdita netta:
$-50.92M
Rapporto P/E:
-13.77
EPS:
-1
Flusso di cassa netto:
$-100.85M
1 W Prestazione:
+5.52%
1M Prestazione:
-1.92%
6M Prestazione:
-42.32%
1 anno Prestazione:
-57.47%
Intervallo 1D:
$13.00
$14.40
Intervallo di 1 settimana:
$12.39
$14.40
Portata 52W:
$11.70
$34.75
Prothena Corporation Plc Stock (PRTA) Company Profile
Nome
Prothena Corporation Plc
Settore
Industria
Telefono
011-353-1-236-2500
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Confronta PRTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
13.77 | 740.44M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-01-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-04-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-27 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-06-18 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Reiterato | Oppenheimer | Outperform |
| 2021-05-26 | Iniziato | Citigroup | Buy |
| 2021-02-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-07 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Downgrade | Jefferies | Buy → Hold |
| 2018-04-05 | Reiterato | Barclays | Overweight |
| 2017-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2017-09-29 | Reiterato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Jefferies | Buy |
| 2017-04-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2017-03-02 | Iniziato | Instinet | Buy |
| 2016-12-21 | Iniziato | SunTrust | Buy |
| 2016-11-03 | Iniziato | Deutsche Bank | Buy |
| 2016-08-04 | Reiterato | Barclays | Overweight |
| 2016-05-13 | Iniziato | Barclays | Overweight |
| 2016-02-19 | Reiterato | Wedbush | Outperform |
| 2016-01-21 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
JPMorgan Chase & Co. Lowers Holdings in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
JPMorgan Chase & Co. Has $3.35 Million Stock Position in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Hennion & Walsh Asset Management Inc. Buys Shares of 52,284 Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena (NASDAQ:PRTA) Shares Up 6.8%Time to Buy? - MarketBeat
Trading (PRTA) With Integrated Risk Controls - Stock Traders Daily
Barclays PLC Grows Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Barclays PLC - Defense World
Prothena (NASDAQ:PRTA) Stock Price Down 9%Here's What Happened - MarketBeat
Prothena (NASDAQ:PRTA) Trading Up 6.5%What's Next? - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Receives $52.29 Average Price Target from Analysts - Defense World
Prothena Corporation plc (NASDAQ: PRTA) Down -6.92%: Here’s What Analysts’ Predictions Are Now. - Stocks Register
Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Price Target at $52.29 - MarketBeat
Prothena (NASDAQ:PRTA) Trading Down 2.6%Time to Sell? - MarketBeat
Prothena Corporation PLC (NASDAQ:PRTA) Director Oleg Nodelman Resigns - Defense World
Prothena Director Oleg Nodelman Steps Down After 5-Year Tenure, Ahead of Major 2025 Clinical Milestones - StockTitan
Prothena Co. plc (NASDAQ:PRTA) Shares Sold by Geode Capital Management LLC - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by Barclays PLC - Defense World
Barclays PLC Buys 49,916 Shares of Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
How the (PRTA) price action is used to our Advantage - Stock Traders Daily
We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate - Yahoo Finance
Prothena Co. plc (NASDAQ:PRTA) Position Trimmed by State Street Corp - Defense World
Prothena Co. plc (NASDAQ:PRTA) Holdings Decreased by State Street Corp - MarketBeat
Prothena Surges After Parkinson's Drug Misses Primary Endpoint - Seeking Alpha
Prothena (NASDAQ:PRTA) Earns Buy Rating from HC Wainwright - MarketBeat
Prothena (NASDAQ:PRTA) Coverage Initiated at Chardan Capital - MarketBeat
Demystifying Prothena Corp: Insights From 6 Analyst Reviews - Benzinga
Even after rising 16% this past week, Prothena (NASDAQ:PRTA) shareholders are still down 67% over the past three years - Simply Wall St
Prothena Corp (NASDAQ:PRTA) Stock Quotes, Forecast and News Summary - Benzinga
Prothena Shares Surge 43% Despite Setback in Parkinson's Drug Trial, Investors Eye Future Potential - mediahousepress
Prothena stock soars despite study miss By Investing.com - Investing.com Canada
Prothena stock soars despite study miss - Investing.com
Prothena (NASDAQ:PRTA) Price Target Cut to $22.00 by Analysts at Bank of America - MarketBeat
Why Is Prothena Corp Stock Soaring Today?Roche Holding (OTC:RHHBY) - Benzinga
Prothena shares price target cut after Parkinson's study miss By Investing.com - Investing.com UK
Prothena stock gains despite Parkinson’s setback (RHHBY:OTCQX) - Seeking Alpha
Prothena’s Parkinson’s study fails primary endpoint despite some success - Yahoo Finance
Prothena (NASDAQ:PRTA) Hits New 52-Week LowHere's Why - MarketBeat
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease - Business Wire
Prothena (NASDAQ:PRTA) Stock Price Down 3.6%Should You Sell? - MarketBeat
Prothena (NASDAQ:PRTA) Stock Price Up 7.8%What's Next? - MarketBeat
Where are the Opportunities in (PRTA) - Stock Traders Daily
Prothena's SWOT analysis: biotech stock's high-risk, high-reward pipeline - Investing.com
Oppenheimer bullish on Prothena stock, sees $1B opportunity for birtamimab in rare disease - Investing.com Nigeria
Janus Henderson Group PLC Sells 1,008,511 Shares of Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena (NASDAQ:PRTA) Reaches New 1-Year LowWhat's Next? - MarketBeat
Charles Schwab Investment Management Inc. Decreases Stock Position in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Why Is Prothena (PRTA) Down 17.9% Since Last Earnings Report? - Yahoo Finance
Wellington Management Group LLP Has $69.91 Million Holdings in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
FY2024 EPS Estimates for Prothena Increased by Analyst - MarketBeat
Systematic Financial Management LP Sells 185,638 Shares of Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena Corporation Plc Azioni (PRTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
4.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):